1. Home
  2. LASR vs RCUS Comparison

LASR vs RCUS Comparison

Compare LASR & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LASR
  • RCUS
  • Stock Information
  • Founded
  • LASR 2000
  • RCUS 2015
  • Country
  • LASR United States
  • RCUS United States
  • Employees
  • LASR N/A
  • RCUS N/A
  • Industry
  • LASR Semiconductors
  • RCUS Biotechnology: Pharmaceutical Preparations
  • Sector
  • LASR Technology
  • RCUS Health Care
  • Exchange
  • LASR Nasdaq
  • RCUS Nasdaq
  • Market Cap
  • LASR 903.8M
  • RCUS 906.4M
  • IPO Year
  • LASR 2018
  • RCUS 2018
  • Fundamental
  • Price
  • LASR $27.16
  • RCUS $10.55
  • Analyst Decision
  • LASR Strong Buy
  • RCUS Buy
  • Analyst Count
  • LASR 6
  • RCUS 8
  • Target Price
  • LASR $26.42
  • RCUS $20.71
  • AVG Volume (30 Days)
  • LASR 1.0M
  • RCUS 805.6K
  • Earning Date
  • LASR 08-07-2025
  • RCUS 08-06-2025
  • Dividend Yield
  • LASR N/A
  • RCUS N/A
  • EPS Growth
  • LASR N/A
  • RCUS N/A
  • EPS
  • LASR N/A
  • RCUS N/A
  • Revenue
  • LASR $216,913,000.00
  • RCUS $262,000,000.00
  • Revenue This Year
  • LASR $13.20
  • RCUS N/A
  • Revenue Next Year
  • LASR $8.66
  • RCUS $28.73
  • P/E Ratio
  • LASR N/A
  • RCUS N/A
  • Revenue Growth
  • LASR 9.79
  • RCUS 6.07
  • 52 Week Low
  • LASR $6.20
  • RCUS $6.50
  • 52 Week High
  • LASR $28.43
  • RCUS $18.98
  • Technical
  • Relative Strength Index (RSI)
  • LASR 70.15
  • RCUS 65.23
  • Support Level
  • LASR $25.70
  • RCUS $9.73
  • Resistance Level
  • LASR $28.43
  • RCUS $10.23
  • Average True Range (ATR)
  • LASR 1.34
  • RCUS 0.51
  • MACD
  • LASR 0.44
  • RCUS 0.10
  • Stochastic Oscillator
  • LASR 76.16
  • RCUS 90.79

About LASR nLIGHT Inc.

nLight Inc is a United States-based company provider of power semiconductor and fiber lasers for aerospace and defense, industrial, and microfabrication applications. It designs, manufactures, and sells a range of power semiconductor lasers and fiber lasers that are typically integrated into laser systems. It operates in two segments: Laser Products, which includes semiconductor lasers, fiber lasers, and directed energy products; and Development segment includes revenue earned from research and development contracts. The majority of its revenue is generated from the Laser segment. The company's geographical segments include North America, Asia Pacific, and EMEA.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

Share on Social Networks: